Login to Your Account



All Fat and Happy

Separating Good from Bad PPAR Gamma Effects May Be Possible

By Anette Breindl
Science Editor

Monday, November 14, 2011

Results from a study published this week suggest a way to get the benefits of one class of diabetes drugs – thiazolidinediones, or TZDs, such Actos (pioglitazone, Takeda Pharmaceutical Co. Ltd.) and Avandia (rosiglitazone, GlaxoSmithKline plc) – without their side effects.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription